These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
289 related articles for article (PubMed ID: 3352511)
1. Opsoclonus, myoclonus, ataxia, and encephalopathy in adults with cancer: a distinct paraneoplastic syndrome. Anderson NE; Budde-Steffen C; Rosenblum MK; Graus F; Ford D; Synek BJ; Posner JB Medicine (Baltimore); 1988 Mar; 67(2):100-9. PubMed ID: 3352511 [TBL] [Abstract][Full Text] [Related]
2. Paraneoplastic opsoclonus: a neuropathologic study of two cases. Giordana MT; Soffietti R; Schiffer D Clin Neuropathol; 1989; 8(6):295-300. PubMed ID: 2559825 [TBL] [Abstract][Full Text] [Related]
3. Neuropathologic findings in idiopathic opsoclonus and myoclonus. Their similarity to those in paraneoplastic cerebellar cortical degeneration. Hunter S; Kooistra C J Clin Neuroophthalmol; 1986 Dec; 6(4):236-41. PubMed ID: 2947929 [TBL] [Abstract][Full Text] [Related]
4. Autopsy case of opsoclonus-myoclonus-ataxia and cerebellar cognitive affective syndrome associated with small cell carcinoma of the lung. Ohara S; Iijima N; Hayashida K; Oide T; Katai S Mov Disord; 2007 Jul; 22(9):1320-4. PubMed ID: 17534981 [TBL] [Abstract][Full Text] [Related]
9. Opsoclonus-myoclonus syndrome as a paraneoplastic manifestation of renal cell carcinoma. a case report and review of the literature. De Luca S; Terrone C; Crivellaro S; De Zan A; Polo P; Vigliani MC; Tizzani A Urol Int; 2002; 68(3):206-8. PubMed ID: 11919472 [TBL] [Abstract][Full Text] [Related]
10. Opsoclonus-Ataxia Syndrome in a Patient With Small-Cell Lung Cancer Treated With Immune Checkpoint Inhibitors. Farina A; Villagrán-García M; Benaiteau M; Lamblin F; Fourier A; Honnorat J; Joubert B Neurol Neuroimmunol Neuroinflamm; 2024 Sep; 11(5):e200287. PubMed ID: 39013128 [TBL] [Abstract][Full Text] [Related]
11. Treatment-refractory paraneoplastic opsoclonus-myoclonus syndrome in a patient with small-cell carcinoma of the lung. Alkan A; Cenikli U; Uylaş S; Yılmaz M; Çakır T; Çetinkaya H; Kıran A; Tanrıverdi Ö J Oncol Pharm Pract; 2020 Jan; 26(1):209-211. PubMed ID: 30791855 [TBL] [Abstract][Full Text] [Related]